Newsroom
Sorted by: Latest
-
Samenvatting: Sai Life Sciences werft meer dan 700 professionals aan in boekjaar 2027
HYDERABAD, India--(BUSINESS WIRE)--Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), een van India’s toonaangevende geïntegreerde CRDMO's (Contract Research, Development & Manufacturing Organizations), maakte vandaag plannen bekend om tijdens 2026-27 meer dan 700 wetenschappelijke, technische en beheerprofessionals aan te werven nu het bedrijf haar capaciteiten op schaal brengt om te beantwoorden aan de wereldwijd stijgende vraag naar end-to-end services voor het ontdekken, het ontwik...
-
Oberon Investments Plc UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Oberon Investments Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be nam...
-
ISG to Assess Palantir Ecosystem Partners
STAMFORD, Conn.--(BUSINESS WIRE)--ISG has launched a study of providers in the Palantir ecosystem and their consulting, implementation, operations and AI-driven analytics capabilities....
-
Acadia Healthcare to Participate in March Investor Conferences
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & Associates’ 47th Annual Institutional Investors Conference, being held March 1-4, 2026, in Orlando, Florida. The Company’s presentation/fireside chat will begin at 11:35 a.m. Eastern Time/10:35 a.m. Central Time. On Monday, March 9, 2026, the Com...
-
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s announces USFDA acceptance to review its Biologics License Application (BLA) for proposed interchangeable biosimilar, Abatacept....
-
Sunbit Earns Spot on the 2026 Forbes Fintech 50, Cementing Its Leadership
LOS ANGELES--(BUSINESS WIRE)--Sunbit today announced its inclusion on the 2026 Forbes Fintech 50 list for the third consecutive year....
-
Balmain Beauty presenta Destin de Balmain: una nueva fragancia de prestigio
PARÍS--(BUSINESS WIRE)--Balmain Beauty presenta Destin de Balmain, su primera fragancia de prestigio. La nueva fragancia femenina es un “eau de parfum” atrevido, floral y afrutado que captura la energía arrolladora de la mujer Balmain: independiente, joven y sin complejos. LA HISTORIA: VIVE TU DESTINO Destin de Balmain es el destino que está en tus manos, un viaje de optimismo y posibilidades infinitas. La fragancia, en presentación recargable, une a quienes se expresan sin reglas ni expectativ...
-
Riassunto: Balmain Beauty presenta Destin de Balmain: la nuova fragranza di prestigio
PARIGI--(BUSINESS WIRE)--Balmain Beauty lancia Destin de Balmain e debutta nel mondo dei profumi di alta gamma. La nuova fragranza donna è un'eau de parfum audace dagli accordi fruttati e floreali che cattura l'inarrestabile energia della donna secondo Balmain: indipendente, giovanile e sempre a testa alta. LA STORIA: VIVI IL TUO DESTINO Destin de Balmain è il destino nelle tue mani, un viaggio di ottimismo e di infinite possibilità, una fragranza refill irresistibile per chi esprime sé stessa...
-
Balmain Beauty apresenta Destin de Balmain: uma nova fragrância de prestígio
PARIS--(BUSINESS WIRE)--A Balmain Beauty revela Destin de Balmain, sua fragrância de prestígio de estreia. A nova fragrância feminina é uma eau de parfum floral frutada ousada, que captura a energia imparável da mulher Balmain: independente, jovem e sem pedir desculpas. A HISTÓRIA: VIVA O SEU DESTINO Destin de Balmain é o destino que você tem nas mãos, uma jornada de otimismo e possibilidades infinitas. A fragrância recarregável une aqueles que se expressam sem regras ou expectativas. Inspirada...
-
Balmain Beauty présente Destin de Balmain : un nouveau parfum de prestige
PARIS--(BUSINESS WIRE)--Balmain Beauty dévoile Destin de Balmain, son premier parfum de prestige. Cette nouvelle fragrance féminine est une eau de parfum audacieuse, florale et fruitée, qui capture l’énergie irrépressible de la femme Balmain : indépendante, jeune et assumée. L’HISTOIRE : VIVEZ VOTRE DESTIN Destin de Balmain, c’est le destin que vous tenez entre vos mains, un voyage optimiste aux possibilités infinies. Ce parfum rechargeable réunit ceux qui s’expriment sans règles ni attentes. I...